Abstract

Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design

Author(s): Patel Gopesh, Davis Countaney, Liu Yi, Ip Kendice, Debideen Krystal E, Anderson Stephanie, Byrne Robert, Herr Dylan, Rhoads Melissa Merrell, Caputo Ross, Banov Daniel, Bassani August S

Issue: Jan/Feb 2021 - Volume 25, Number 1

Page(s): 73-81

Download in electronic PDF format for $75
  • Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design Page 1
  • Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design Page 2
  • Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design Page 3
  • Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design Page 4
  • Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design Page 5
  • Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design Page 6
  • Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design Page 7
  • Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design Page 8
  • Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design Page 9

Abstract

Trimix is a widely prescribed penile injection for patients with erectile dysfunction and is only available as a compounded medication. The instability of alprostadil, one of the major ingredients of Trimix, has been a limiting factor in its utilization. There are published stability data for Trimix formulations that have been used to establish a beyond-use-date. However, a robust bracketed study that is shown to be reproducible is highly desirable and meaningful. The purpose of this study was to test the reproducibility of a bracketed stability study when the preparations were made by two different entities to provide beyond-use date information of Trimix preparations that cover a wide range of strengths. A validated stability indicating method was used to compare the stability of a bracketed Trimix - alprostadil 5 µg/mL to 45 µg/mL, papaverine 15 mg/mL to 30 mg/mL, and phentolamine 0.4 mg/mL to 5 mg/mL, and a single-strength preparation containing alprostadil 30 µg/mL, papaverine 30 mg/mL, and phentolamine 2 mg/mL that were compounded and stored following the same methods and conditions, but at two different practice settings. Beyond-use dates of 60 days and 64 days at cold temperature were obtained for the two preparations from two different settings. The consistent results confirmed the reproducibility of the bracketing designs used to determine the beyond-use dates of Trimix. The clinical value of these results stems from the availability of accurate and widely applicable stability data that can be referenced to establish beyond use dates of a number of Trimix preparations with various strength combinations.

Related Keywords

  • Trimix
  • penile injection
  • intracavernosal injection
  • corpora cavernosum
  • erectile dysfunction
  • penile erection
  • alprostadil
  • prostaglandin E1
  • papaverine hydrochloride
  • smooth muscle relaxant
  • cyclic adenosine monophosphate agonist
  • phentolamine mesylate
  • vasoconstriction blocker
  • vasodilator
  • drug admixture stability
  • physical stability
  • chemical stability
  • beyond-use date
  • formulations
  • aseptic preparations
  • compounded sterile preparations

Related Categories

  • PARENTERALS
  • PEER-REVIEWED
  • STABILITIES, COMPATIBILITIES
  • INFECTIOUS DISEASE

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 2021
Pg. 73-81
Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design
Author(s): Patel Gopesh, Davis Countaney, Liu Yi, Ip Kendice, Debideen Krystal E, Anderson Stephanie, Byrne Robert, Herr Dylan, Rhoads Melissa Merrell, Caputo Ross, Banov Daniel, Bassani August S
May/Jun 2004
Pg. 231-235
Long-Term Stability of Trimix: A Three-Drug Injection Used to Treat Erectile Dysfunction.
Author(s): Trissel Lawrence A, Zhang Yanping
Jan/Feb 2021
Pg. 18-23
Reversing Erectile Dysfunction and Urinary Incontinence After Prostatectomy or Radiotherapy: The Stanley Prostate-Cancer Treatment Protocol
Author(s): McKettrick Greg, Yoch Doug
Mar/Apr 2018
Pg. 129-134
Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy
Author(s): Rhoads Rick
Mar/Apr 2021
Pg. 94-98
The Stanley Prostate-cancer Treatment Protocol for Erectile Dysfunction After Prostatectomy and/or Radiotherapy: A Case Report
Author(s): McKettrick Greg, Yoch Doug
May/Jun 2003
Pg. 171
Prostaglandin E1/Papaverine HCl/Phentolamine Mesylate Injection
Author(s): Meece Jerry
Mar/Apr 1999
Pg. 134
Prostaglandin E1/Papaverine HCl/Phentolamine Mesylate Injection
Author(s): Allen Loyd V Jr
Mar/Apr 1999
Pg. 160-163
In Vitro Transdermal Delivery and Stability of Liposome-Encapsulated Prostaglandin E1
Author(s): Foldvari Marianna, Oguejifor Cosmas
Mar/Apr 1997
Pg. 132-134
Stability of Aminocaproic Acid Injection Admixtures in 5% Dextrose Injection and 0.9% Sodium Chloride Injection
Author(s): Zhang Yan-ping, Trissel Lawrence A
Mar/Apr 1999
Pg. 81
Medication Combinations for Penile Injections
Author(s): Preckshot John
May/Jun 2021
Pg. 236-240
Stability Evaluation of Minoxidil in FOAMIL Foam Base with Bracketing Study Design
Author(s): Lupatini Rodrigo, Sidhu Raman, Patel Harshad, Bichar Katia
Nov/Dec 2014
Pg. 456-460
Standards of Practice, Professional Judgment, and Scientific Evidence to Establish and Extend a Beyond-Use Date
Author(s): Thomson Cassandra Marie, Savji Taslim
Nov/Dec 2012
Pg. 471-474
Beyond-use Date: Establishment and Maintenance
Author(s): Osteen Richard
Nov/Dec 2012
Pg. 507
Papaverine Hydrochloride 30-mg/mL Injection
Author(s): Allen Loyd V Jr
May/Jun 2003
Pg. 170-174
Five Compounds for Treating Diabetes-Related Conditions
Author(s): Meece Jerry
Jul/Aug 2018
Pg. 303-312
Basics of Sterile Compounding: Criteria for Determining Beyond-use Dating
Author(s): Martin Matt
Mar/Apr 2017
Pg. 150-153
Stability of Alprostadil in 0.9% Sodium Chloride Stored in Polyvinyl Chloride Containers
Author(s): McCluskey Susan V, Kirkham Kylian, Munson Jessica M
Mar/Apr 2010
Pg. 105-107
Determining the Causes of Erectile Dysfunction: Can Medications Be a Double-Sided Sword?
Author(s): Williams LaVonn A
Mar/Apr 2007
Pg. 122-124
Compounded Treatments for Erectile Dysfunction: A Common Complication of Diabetes
Author(s): Fields Shannon W
Nov/Dec 2008
Pg. 524-528
Quality-Control Analytical Methods: Overview of Beyond-Use Dating for Compounded Sterile Preparations
Author(s): Trissel Lawrence A